ImmunoGen (IMGN)
ImmunoGen Market Cap: 1.099B
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
IMGN Market Cap Rankings
| Overall | 62nd percentile | 1762 of 4663 |
| Sector | 74th percentile | 135 of 525 in Healthcare |
| Industry | 84th percentile | 25 of 164 in Biotechnology |
IMGN Market Cap Range, Past 5 Years
| Minimum | 131.30M | Jun 2008 |
| Maximum | 1.104B | Mar 2012 |
| Average | 510.63M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
You may also be interested in these IMGN related companies
IMGN News
$IMGN http://stks.co/3yyo Trading Ideas for Fri May 25: $IMGN $BBBY $FL http://stks.co/3yyp
about 6 days ago by TraderHR
about 6 days ago by TraderHR
$IMGN http://stks.co/3vUP could break out of multi-month consolidation, watch for a move above $15 http://stks.co/3vUQ
about 9 days ago by TraderHR
about 9 days ago by TraderHR
RT @adamfeuerstein Orbimed Advisors top 5 new buys in Q1: $ONXX $CCXI $IMGN $NBIX $ARRY, per 13F #biotech
about 14 days ago by WolfsBiotechs
about 14 days ago by WolfsBiotechs
ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences
May 08, 6:30AM Business Wire
May 08, 6:30AM Business Wire
News related to $IMGN, currently 0.0% since open: 'ImmunoGen fiscal 3Q loss widens as expenses rise' http://stks.co/3YQ1
about 33 days ago by TradeBot
about 33 days ago by TradeBot
Listen to $IMGN Q3 2012 earnings call - live at 08:00 AM, ondemand after - http://stks.co/3Y1e
about 33 days ago by earningscast
about 33 days ago by earningscast
ImmunoGen, Inc. Reports Third Quarter Fiscal Year 2012 Financial Results and Provides Quarterly Update
Apr 27, 6:30AM Business Wire
Apr 27, 6:30AM Business Wire
ImmunoGen, Inc. Announces Conference Call to Discuss its Third Quarter Fiscal Year 2012 Financial Results
Apr 18, 4:15PM Business Wire
Apr 18, 4:15PM Business Wire
ImmunoGen, Inc. Announces the IND Is Now Active for Its Folate-Receptor Targeting Anticancer Compound, IMGN853
Apr 17, 6:30AM Business Wire
Apr 17, 6:30AM Business Wire
ImmunoGen, Inc. Initiates Phase I Trial in Non-Hodgkin’s Lymphoma with Its Novel IMGN529 Anticancer Compound
Apr 17, 6:15AM Business Wire
Apr 17, 6:15AM Business Wire
ImmunoGen (IMGN) Pops Higher Following Positive T-DM1 Phase III Results
Mar 30, 8:24AM Street Insider
Mar 30, 8:24AM Street Insider
ImmunoGen (IMGN) Reports Positive Top-Line Results from T-DM1 EMILIA Phase III
Mar 30, 8:22AM Street Insider
Mar 30, 8:22AM Street Insider
ImmunoGen Announces Initiation of Phase II Evaluation of Its IMGN901 Product Candidate
Mar 30, 6:42AM Benzinga
Mar 30, 6:42AM Benzinga
ImmunoGen, Inc. Announces Initiation of Phase II Evaluation of Its IMGN901 Product Candidate
Mar 30, 6:00AM Business Wire
Mar 30, 6:00AM Business Wire
ImmunoGen, Inc. Announces Positive Results in Trastuzumab Emtansine (T-DM1) EMILIA Phase III Trial
Mar 30, 1:01AM Business Wire
Mar 30, 1:01AM Business Wire
$IMGN forms bullish "Continuation Diamond" chart pattern. http://stks.co/2tSZ
about 76 days ago by RecogniaEvents
about 76 days ago by RecogniaEvents
ImmunoGen, Inc. Announces Webcast of Presentation at the Cowen 32nd Annual Health Care Conference
Mar 02, 3:00PM Business Wire
Mar 02, 3:00PM Business Wire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| IMGN | 14.32 | -0.15 | -1.04% | 1.111B |
| IMC | 15.21 | -0.07 | -0.47% | |
| IMAX | 21.42 | -0.55 | -2.50% | 1.435B |
| IM | 18.02 | -0.07 | -0.39% | 2.715B |
| ILMN | 44.20 | +0.00 | +0.00% | 5.448B |
| ILF | 40.15 | -0.64 | -1.57% | |
| IL | 4.07 | -0.14 | -3.33% | 230.50M |
| MCD | 90.01 | -0.89 | -0.98% | 92.59B |
| MCBF | 1.15 | -0.09 | -7.26% | 2.358M |
| MCBC | 3.278 | +0.03 | +0.85% | 88.76M |